Aegis initiated coverage on shares of Ingevity Corp (NASDAQ:NGVT) in a research report sent to investors on Tuesday. The brokerage issued a buy rating on the stock.

Other equities analysts also recently issued research reports about the stock. SunTrust Banks Inc. reiterated a buy rating on shares of Ingevity Corp in a report on Saturday, August 6th. Zacks Investment Research downgraded shares of Ingevity Corp from a hold rating to a sell rating in a report on Thursday, November 3rd. Jefferies Group started coverage on shares of Ingevity Corp in a research note on Friday, September 23rd. They issued a buy rating and a $57.00 price objective on the stock. Buckingham Research started coverage on shares of Ingevity Corp in a research note on Friday, September 23rd. They issued a neutral rating on the stock. Finally, Oppenheimer Holdings Inc. reissued an outperform rating and issued a $50.00 price objective (up from $44.00) on shares of Ingevity Corp in a research note on Wednesday, September 7th. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of Buy and an average price target of $48.60.

Analyst Recommendations for Ingevity Corp (NASDAQ:NGVT)

Shares of Ingevity Corp (NASDAQ:NGVT) traded up 0.66% on Tuesday, hitting $52.07. 24,870 shares of the company traded hands. Ingevity Corp has a 12 month low of $24.71 and a 12 month high of $52.94. The company has a market capitalization of $2.19 billion and a PE ratio of 67.54. The stock’s 50-day moving average price is $44.64 and its 200-day moving average price is $40.28.

Ingevity Corp (NASDAQ:NGVT) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported $0.64 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.61 by $0.03. The company earned $252 million during the quarter, compared to analysts’ expectations of $247.60 million. The company’s revenue was down 1.8% on a year-over-year basis. On average, equities analysts predict that Ingevity Corp will post $1.97 earnings per share for the current year.

Several hedge funds have recently bought and sold shares of NGVT. Teacher Retirement System of Texas purchased a new stake in Ingevity Corp during the second quarter worth about $202,000. Vanguard Group Inc. bought a new position in Ingevity Corp during the second quarter worth about $118,442,000. Ameriprise Financial Inc. bought a new position in Ingevity Corp during the second quarter worth about $7,333,000. PineBridge Investments L.P. bought a new position in Ingevity Corp during the second quarter worth about $181,000. Finally, Brown Advisory Inc. bought a new position in Ingevity Corp during the second quarter worth about $436,000.

ILLEGAL ACTIVITY NOTICE: This report was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this report can be accessed at https://www.thecerbatgem.com/2016/11/23/ingevity-corp-ngvt-receives-new-coverage-from-analysts-at-aegis.html.

Ingevity Corp Company Profile

Ingevity Corporation is a manufacturer of specialty chemicals, carbon materials and technologies. The Company operates through two segments: Performance Materials and Performance Chemicals. The Company’s specialty chemicals products serve as inputs used in a range of high performance applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants and printing inks.

5 Day Chart for NASDAQ:NGVT

Receive News & Stock Ratings for Ingevity Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corp and related stocks with our FREE daily email newsletter.